Journal article
Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer
- Abstract:
-
Objective: Symptom-triggered testing for ovarian cancer was introduced to the UK whereby symptomatic women undergo an ultrasound scan and serum CA125, and are referred to hospital within 2 weeks if these are abnormal. The potential value of symptom-triggered testing in the detection of early-stage disease or low tumor burden remains unclear in women with high grade serous ovarian cancer. In this descriptive study, we report on the International Federation of Gynecology and Obstetrics (FIGO) s...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of Record, Version of record, pdf, 647.0KB, Terms of use)
-
- Publisher copy:
- 10.1136/ijgc-2024-005371
Authors
- Publisher:
- BMJ Publishing Group
- Journal:
- International Journal of Gynecological Cancer More from this journal
- Article number:
- ijgc-2024-005371
- Publication date:
- 2024-07-24
- Acceptance date:
- 2024-06-10
- DOI:
- EISSN:
-
1525-1438
- ISSN:
-
1048-891X
- Language:
-
English
- Keywords:
- Pubs id:
-
2032991
- Local pid:
-
pubs:2032991
- Source identifiers:
-
2266111
- Deposit date:
-
2024-09-17
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2024
If you are the owner of this record, you can report an update to it here: Report update to this record